• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Celgene Corporation (CELG)

    -NasdaqGS
    117.18 Up 0.70(0.60%) Dec 19, 4:00PM EST
    |After Hours : 117.18 0.00 (0.00%) Dec 19, 7:31PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 6,493,900   5,506,700   4,842,100  
    Cost of Revenue340,400  299,100  425,900  
    Gross Profit 6,153,500   5,207,600   4,416,200  
    Operating Expenses
    Research Development2,226,200  1,724,200  1,600,300  
    Selling General and Administrative1,684,500  1,373,500  1,226,300  
    Non Recurring171,100  169,000  (142,300)
    Others262,800  194,500  289,200  
    Total Operating Expenses4,344,600  3,461,200  2,973,500  
    Operating Income or Loss 1,808,900   1,746,400   1,442,700  
    Income from Continuing Operations
    Total Other Income/Expenses Net(51,900)(1,700)19,500  
    Earnings Before Interest And Taxes1,757,000  1,744,700  1,462,200  
    Interest Expense91,600  63,200  42,700  
    Income Before Tax1,665,400  1,681,500  1,419,500  
    Income Tax Expense215,500  225,300  102,100  
    Minority Interest -   -  700  
    Net Income From Continuing Ops1,449,900  1,456,200  1,318,100  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 1,449,900   1,456,200   1,318,100  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 1,449,900   1,456,200   1,318,100  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.